Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), Voglibose IP (0.3 mg) is an advanced triple-combination anti-diabetic formulation developed for effective management of Type 2 diabetes mellitus. Available under the brand name GLICLAGLAZE TRIO 40/0.3, this medicine combines the glucose-lowering benefits of Gliclazide, Metformin, and Voglibose.
This combination is prescribed when diet, exercise, and single or dual-drug therapy are not sufficient to achieve proper glycemic control. Gliclazide Metformin Hydrochloride and Voglibose Tablets help control fasting, post-meal, and long-term blood sugar levels.
What is GLICLAGLAZE TRIO 40/0.3?
GLICLAGLAZE TRIO 40/0.3 is an oral anti-diabetic medicine containing:
Gliclazide IP 40 mg
Metformin Hydrochloride IP 500 mg
Voglibose IP 0.3 mg
This triple-action formula helps manage blood glucose more effectively and is commonly prescribed as Triple Combination Tablets for Type 2 Diabetes.
Mechanism of Action
1. Gliclazide Action
Gliclazide stimulates insulin secretion from pancreatic beta cells, helping lower blood glucose.
2. Metformin Action
Metformin reduces glucose production in the liver and improves insulin sensitivity.
3. Voglibose Action
Voglibose slows carbohydrate digestion and reduces post-meal glucose spikes.
These combined actions make Gliclazide Metformin Hydrochloride Voglibose Combination Tablets highly effective in diabetes care.
Uses and Indications
GLICLAGLAZE TRIO 40/0.3 is indicated for:
1. Type 2 Diabetes Mellitus
Used as Diabetes Treatment Tablets with Voglibose and Metformin for long-term blood sugar management.
2. Post-Meal Sugar Control
Acts as Post Meal Blood Sugar Control Medicine.
3. Patients Requiring Triple Therapy
Suitable when single or dual anti-diabetic therapy is insufficient.
4. Prevention of Diabetes Complications
Helps reduce complications associated with uncontrolled diabetes.
Because of its effectiveness, it is considered among the Best Tablets for Type 2 Diabetes Management.
Efficacy and Clinical Evidence
Clinical studies show that the combination of Gliclazide, Metformin, and Voglibose can provide:
Improved fasting glucose control
Reduced post-prandial sugar levels
Better HbA1c reduction
Enhanced insulin efficiency
This makes Gliclazide Metformin Voglibose Anti Diabetic Medicine a trusted option in diabetes treatment.
Side Effects and Safety Profile
Common side effects may include:
Nausea
Abdominal discomfort
Gas or bloating
Mild diarrhea
Headache
Possible serious side effects:
Hypoglycemia
Sweating
Weakness
Dizziness
Overall, Prescription Diabetes Medicine Gliclazide Metformin Voglibose is generally well tolerated when used under medical supervision.
Contraindications and Precautions
Do not use this medicine if:
Allergic to any of its components
Severe kidney disease
Severe liver disease
Diabetic ketoacidosis
Use cautiously in:
Elderly patients
Patients with dehydration
Patients with nutritional deficiencies
Patients undergoing surgery
Drug Interactions
This medicine may interact with:
Insulin
Steroids
Blood pressure medications
Antibiotics
Alcohol
Always inform your doctor about all medicines and supplements you are taking.
Warnings and Regulatory Status
GLICLAGLAZE TRIO is a prescription medicine in countries including India.
Important warnings:
Do not skip meals
Monitor blood sugar regularly
Avoid excessive alcohol consumption
Follow prescribed dosage carefully
Patient Advice and Tips
For best results:
Take with meals
Follow a diabetic diet
Exercise regularly
Monitor glucose routinely
Do not stop treatment without consulting your doctor
These Oral Anti Diabetic Tablets for Glucose Control work best when combined with lifestyle modifications.
Availability
Available through licensed pharmacies and healthcare distributors.
Patients often search online using terms like:
Buy Gliclazide Metformin Voglibose Tablets Online
Gliclazide Metformin Voglibose Tablets Product Image
Voglibose 0.3 mg Metformin 500 mg Gliclazide 40 mg Tablets
Metformin Hydrochloride Voglibose and Gliclazide Tablets IP
Blood Sugar Control Tablets for Diabetes Patients
Frequently Asked Questions (FAQs)
1. What is GLICLAGLAZE TRIO 40/0.3 used for?
It is used for managing Type 2 diabetes mellitus and controlling blood sugar levels.
2. Does this medicine control post-meal sugar?
Yes, voglibose helps reduce post-meal sugar spikes.
3. When should I take this medicine?
Usually with meals, as advised by your doctor.
4. Can it cause low blood sugar?
Yes, especially if meals are skipped.
5. Can it be used for long-term diabetes treatment?
Yes, under regular medical supervision.
Conclusion
GLICLAGLAZE TRIO 40/0.3 containing Gliclazide, Metformin, and Voglibose provides comprehensive blood glucose control for patients with Type 2 diabetes.
Whether you are looking for Gliclazide Metformin Hydrochloride and Voglibose Tablets, Triple Combination Tablets for Type 2 Diabetes, or Post Meal Blood Sugar Control Medicine, GLICLAGLAZE TRIO offers reliable diabetes management under medical supervision.
